Coronary atherosclerosis
Clinical trials for Coronary atherosclerosis explained in plain language.
Never miss a new study
Get alerted when new Coronary atherosclerosis trials appear
Sign up with your email to follow new studies for Coronary atherosclerosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weight-Loss drug may also protect heart arteries
Disease control Not yet recruitingThis study tests whether mazdutide, a weekly injection that helps with weight loss, can slow the buildup of fatty plaque in the heart arteries of 116 overweight or obese adults with coronary heart disease. Participants will receive either the drug or a placebo for 52 weeks, and d…
Matched conditions: CORONARY ATHEROSCLEROSIS
Phase 4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a purified fish oil calm the 'hot' plaques that trigger heart attacks?
Disease control Not yet recruitingThis trial tests whether icosapent ethyl, a purified form of fish oil, can stabilize high-risk coronary plaques in people with heart disease. Participants have plaques that narrow a major heart artery by 30–70% and show at least one high-risk feature on a CT scan. Half will take …
Matched conditions: CORONARY ATHEROSCLEROSIS
Phase 4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Triple-Drug cocktail aims to reverse early heart disease
Disease control Not yet recruitingThis Phase 3 trial will test whether a combination of three cholesterol-lowering drugs—bempedoic acid, ezetimibe, and a high-intensity statin—can reduce and stabilize plaque buildup in the coronary arteries. The study enrolls 103 adults with coronary atherosclerosis who have neve…
Matched conditions: CORONARY ATHEROSCLEROSIS
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC